Government Housing Assistance May Boost Some Cancer Screening

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 15, 2023.

By Lori Solomon HealthDay Reporter

TUESDAY, Nov. 14, 2023 -- Receipt of government housing assistance is associated with increased rates of breast cancer (BC) and colorectal cancer (CRC) screening, according to a study published online Nov. 8 in the American Journal of Preventive Medicine.

Jordan Baeker Bispo, Ph.D., from the American Cancer Society in Atlanta, and colleagues used data from the 2019 and 2021 National Health Interview Survey to examine the association between cancer screening and receipt of government housing assistance among low-income adults. Analyses included BC, cervical cancer, and CRC screening (2,258; 3,132; and 3,233 respondents, respectively).

The researchers observed no difference in cervical screening by housing assistance status, but screening for BC and CRC was higher among those who received assistance versus those who did not (BC: 59.7 versus 50.8 percent; CRC: 57.1 versus 44.1 percent). However, when adjusting for sociodemographic factors, health status, and insurance, these differences in BC and CRC were not statistically significant. Housing assistance was significantly associated with increased BC screening in urban areas (adjusted odds ratio [aOR], 1.35; 95 percent confidence interval [CI], 1.00 to 1.82), among Hispanic women (aOR, 2.20; 95 percent CI, 1.01 to 4.78), and among women 45 to 54 years of age (aOR, 2.10; 95 percent CI, 1.17 to 3.75).

"Receiving housing assistance has been associated with several positive health outcomes and health behaviors in past research, and our findings suggest it can also support cancer screening in some medically underserved groups," Bispo said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-11-15 09:14

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords